Development and validation of analytical methodology for near-infrared conformance testing of pharmaceutical intermediates

Journal of Pharmaceutical and Biomedical Analysis

Volumn 15, Issue 3, 1996, Pages 315-327

  Forbes, R A ^a   Persinger, M L ^a   Smith, D R ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Conformance testing; Conformity index; Loracarbef; Method validation; Near infrared spectroscopy; Pharmaceutical analysis; Wavelength distance method

Indexed keywords

LORACARBEF;

ACCURACY; ANALYTIC METHOD; ARTICLE; DRUG ANALYSIS; INFRARED SPECTROMETRY; METHODOLOGY; PRIORITY JOURNAL;

CALIBRATION; CHEMISTRY, PHARMACEUTICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, INFRARED;

EID: 0030560949     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(96)01875-4     Document Type: Article

References (12)

1. [1] B.F. MacDonald and K.A. Prebble, J. Pharm. Biomed. Anal., 11 (1993) 1077-1085.
2. [2] P.A. Hailey, A.C.E. Oakley, P. Doherty, A.J. Pettman, D.C.A. Sharp and D.M.H. Barnes, NIR News, 5, No. 3 (1994) 10-12.
3. [3] E.W. Ciurczak and D.A. Burns, (eds.), Handbook of Near-Infrared Analysis, Marcel Dekker, New York. 1992 Ch. 20.
4. [4] E.W. Ciurczak, Appl. Spectrosc. Rev., 23 (1987) 147-163.
5. [5] E.W. Ciurczak and T.A. Maldacker, Spectrosocpy, 1 (1986) 36-39.
6. [6] W.H. Kohn and A.N. Jeger, J. Forensic Sci., 37 (1992) 35-41.
7. [7] W. Paulson and C.P. Werble (eds.), Quality Control Reports - The Gold Sheet', Vol. 28, No. 7, F-D-C Reports, Inc., Chevy Chase, MD, 1994, pp. 1-10.
8. [8] W. Plugge and C. Van Der Vlies, J. Pharm. Biomed. Anal., 10 (1992) 797-803.
9. [9] W. Plugge and C. Van Der Vlies, J. Pharm. Biomed. Anal., 11 (1993) 435-442.
10. [10] P.J. Gemperline and N.R. Boyer, Anal. Chem., 67 (1995) 160-166.
11. [11] 21 CFR Part 210 - Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General, and Part 211 - Current Good Manufacturing Practice for Finished Pharmaceuticals, 43 FR 45076, Section 211.165, USOFR. NARA, Washington, DC, 1978.
12. [12] Validation of Compendial Methods, USP 23, NF 18, United States Pharmacopeial Convention, Inc., Rockville, MD, 1995, pp. 1982-1984.